highly significantp < 0.001
This quantification showed a dramatic and highly significant depletion of CD19+ B cells in AML patients (mean frequency ± standard deviation; HD: 12.4 ± 8.3; AML: 2.9 ± 3.2, p < 0.001) ( Figure 1B ).
This quantification showed a dramatic and highly significant depletion of CD19+ B cells in AML patients (mean frequency ± standard deviation; HD: 12.4 ± 8.3; AML: 2.9 ± 3.2, p < 0.001) ( Figure 1B ).